CSRXP COMMENDS PRESIDENT BIDEN FOR HOLDING BIG PHARMA ACCOUNTABLE FOR PATENT ABUSE AND EGREGIOUS PRICING ON BRAND NAME INHALERS
President Says ‘Drug Companies Are Charging Exorbitant Prices’ in Press… Read More
President Says ‘Drug Companies Are Charging Exorbitant Prices’ in Press… Read More
CBO Says Cost to Taxpayers of Covering GLP-1 Medications Would Outpace Savings… Read More
Big Pharma Exec Downplays “Modest” Drug Pricing Solutions That CEO… Read More
Median Price Set by Brand Name Drug Makers on New Treatments Climbs to… Read More
GLP-1 Weight-Loss Leaders “Blow Past” Wall Street Projections in Q4 2023,… Read More
More Big Pharma Giants Report Earnings That Top Wall Street Expectations While… Read More
Patent Abuse Designed to Extend Monopolies, Block Competition and Keep Prices… Read More
Big Pharma Giants Continue Q4 Earnings Besting Wall Street Expectations Pfizer… Read More
JAMA Analysis Finds Patents for Active Ingredients for Weight Loss Drugs… Read More
Lawmakers and Experts Will Discuss Solutions to Hold Big Pharma Accountable… Read More
Big Pharma Giant Kicks Off Q4 Earnings After Hiking Prices More Than 40 Times… Read More
Big Pharma Price Hikes, Rising Launch Prices And Patent Abuse Impose Massive… Read More